阿戈美拉汀 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "阿戈美拉汀" in Chinese language version.

refsWebsite

Global rank Chinese rank

7nih.gov

4^th place

5^th place

6doi.org

2^nd place

23^rd place

2tga.gov.au

3,984^th place

1,603^rd place

2web.archive.org

1^st place

doi.org

Guaiana G, Gupta S, Chiodo D, Davies SJ, Haederle K, Koesters M. Agomelatine versus other antidepressive agents for major depression. The Cochrane Database of Systematic Reviews. December 2013, (12): CD008851. PMC 11289707 . PMID 24343836. doi:10.1002/14651858.CD008851.pub2.
Pladevall-Vila M, Pottegård A, Schink T, Reutfors J, Morros R, Poblador-Plou B, Timmer A, Forns J, Hellfritzsch M, Reinders T, Hägg D, Giner-Soriano M, Prados-Torres A, Cainzos-Achirica M, Hallas J, Brandt L, Cortés J, Aguado J, Perlemuter G, Falissard B, Castellsagué J, Jacquot E, Deltour N, Perez-Gutthann S. Risk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries: A Cohort and Nested Case-Control Study Using Automated Health Data Sources. CNS Drugs. April 2019, 33 (4): 383–395. PMC 6441103 . PMID 30830574. doi:10.1007/s40263-019-00611-9.
Taylor D, Sparshatt A, Varma S, Olofinjana O. Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies. BMJ. March 2014, 348: g1888. PMC 3959623 . PMID 24647162. doi:10.1136/bmj.g1888.
Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JP, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JP, Geddes JR. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. April 2018, 391 (10128): 1357–1366. PMC 5889788 . PMID 29477251. doi:10.1016/S0140-6736(17)32802-7 （英语）.
Williams WP, McLin DE, Dressman MA, Neubauer DN. Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders. Pharmacotherapy. September 2016, 36 (9): 1028–41. PMC 5108473 . PMID 27500861. doi:10.1002/phar.1822.
Nussbaumer-Streit B, Greenblatt A, Kaminski-Hartenthaler A, Van Noord MG, Forneris CA, Morgan LC, Gaynes BN, Wipplinger J, Lux LJ, Winkler D, Gartlehner G. Melatonin and agomelatine for preventing seasonal affective disorder. The Cochrane Database of Systematic Reviews. June 2019, 2019 (6): CD011271. PMC 6578031 . PMID 31206585. doi:10.1002/14651858.CD011271.pub3.

nih.gov

ncbi.nlm.nih.gov

Guaiana G, Gupta S, Chiodo D, Davies SJ, Haederle K, Koesters M. Agomelatine versus other antidepressive agents for major depression. The Cochrane Database of Systematic Reviews. December 2013, (12): CD008851. PMC 11289707 . PMID 24343836. doi:10.1002/14651858.CD008851.pub2.
Pladevall-Vila M, Pottegård A, Schink T, Reutfors J, Morros R, Poblador-Plou B, Timmer A, Forns J, Hellfritzsch M, Reinders T, Hägg D, Giner-Soriano M, Prados-Torres A, Cainzos-Achirica M, Hallas J, Brandt L, Cortés J, Aguado J, Perlemuter G, Falissard B, Castellsagué J, Jacquot E, Deltour N, Perez-Gutthann S. Risk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries: A Cohort and Nested Case-Control Study Using Automated Health Data Sources. CNS Drugs. April 2019, 33 (4): 383–395. PMC 6441103 . PMID 30830574. doi:10.1007/s40263-019-00611-9.
Taylor D, Sparshatt A, Varma S, Olofinjana O. Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies. BMJ. March 2014, 348: g1888. PMC 3959623 . PMID 24647162. doi:10.1136/bmj.g1888.
Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JP, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JP, Geddes JR. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. April 2018, 391 (10128): 1357–1366. PMC 5889788 . PMID 29477251. doi:10.1016/S0140-6736(17)32802-7 （英语）.
Williams WP, McLin DE, Dressman MA, Neubauer DN. Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders. Pharmacotherapy. September 2016, 36 (9): 1028–41. PMC 5108473 . PMID 27500861. doi:10.1002/phar.1822.
Nussbaumer-Streit B, Greenblatt A, Kaminski-Hartenthaler A, Van Noord MG, Forneris CA, Morgan LC, Gaynes BN, Wipplinger J, Lux LJ, Winkler D, Gartlehner G. Melatonin and agomelatine for preventing seasonal affective disorder. The Cochrane Database of Systematic Reviews. June 2019, 2019 (6): CD011271. PMC 6578031 . PMID 31206585. doi:10.1002/14651858.CD011271.pub3.

pubmed.ncbi.nlm.nih.gov

https://pubmed.ncbi.nlm.nih.gov/27342740/

tga.gov.au

ebs.tga.gov.au

VALDOXAN® Product Information (PDF). TGA eBusiness Services. Servier Laboratories Pty Ltd. 2013-09-23 [2013-10-14]. （原始内容存档于2017-03-24）.
Valdoxan Product Information (PDF). TGA eBusiness Services. Servier Laboratories Pty Ltd. 2013-09-23 [2013-10-14]. （原始内容存档于2017-03-24）.

web.archive.org

VALDOXAN® Product Information (PDF). TGA eBusiness Services. Servier Laboratories Pty Ltd. 2013-09-23 [2013-10-14]. （原始内容存档于2017-03-24）.
Valdoxan Product Information (PDF). TGA eBusiness Services. Servier Laboratories Pty Ltd. 2013-09-23 [2013-10-14]. （原始内容存档于2017-03-24）.